Nucleic Acids Research Acceptance Rate
Nucleic Acids Research's acceptance rate in context, including how selective the journal really is and what the number leaves out.
Senior Researcher, Molecular & Cell Biology
Author context
Specializes in molecular and cell biology manuscript preparation, with experience targeting Molecular Cell, Nature Cell Biology, EMBO Journal, and eLife.
Journal evaluation
Want the full picture on Nucleic Acids Research?
See scope, selectivity, submission context, and what editors actually want before you decide whether Nucleic Acids Research is realistic.
What Nucleic Acids Research's acceptance rate means for your manuscript
Acceptance rate is one signal. Desk rejection rate, scope fit, and editorial speed shape the realistic path more than the headline number.
What the number tells you
- Nucleic Acids Research accepts roughly ~45% of submissions, but desk rejection accounts for a disproportionate share of early returns.
- Scope misfit drives most desk rejections, not weak methodology.
- Papers that reach peer review face a higher bar: novelty and fit with editorial identity.
What the number does not tell you
- Whether your specific paper type (review, letter, brief communication) faces the same rate as full articles.
- How fast you will hear back — check time to first decision separately.
- What open access publishing will cost if you choose that route.
Quick answer: Nucleic Acids Research does not publish a live public acceptance rate on its main journal pages. The practical answer is still clear: NAR is highly selective, screens very quickly, and behaves like a journal that wants either deep mechanistic biology or high-utility community resources. Oxford Academic's current metrics make that easier to see than any guessed percentage.
The Nucleic Acids Research journal page is the best cluster reference if you want to compare this acceptance-rate question against impact factor, review time, and article-type fit.
NAR acceptance-rate context at a glance
Metric | Current figure | Why it matters |
|---|---|---|
Official live acceptance rate on public journal pages | Not published | No clean current official rate |
Median days to first decision (2025) | 18 days | Editorial triage is unusually fast |
Median days to final decision (2025) | 23 days | The journal runs a very quick process overall |
Impact factor (2024) | 13.1 | High citation position in molecular biology |
5-year JIF | 16.8 | Long-tail citation strength matters here |
CiteScore | 31.7 | Confirms strength across a wider citation window |
h5-index | 233 | Strong long-run authority |
That is a better decision table than a made-up acceptance number. NAR is one of the journals where authors get more real signal from the speed and editorial pattern than from any unofficial rate estimate.
Longer-term metrics context
Year | Impact factor |
|---|---|
2017 | 11.6 |
2018 | 11.1 |
2019 | 11.5 |
2020 | 16.9 |
2021 | 19.2 |
2022 | 14.9 |
2023 | 13.1 |
2024 | 13.1 |
The 2024 impact factor was unchanged from 13.1 in 2023 to 13.1 in 2024, which is the useful read after the pandemic-era spike. NAR has normalized back into a very strong, stable upper tier rather than collapsing after the temporary citation surge.
How NAR compares with nearby journals
Journal | Acceptance signal | IF (2024) | Secondary metrics signal | Best fit |
|---|---|---|---|---|
Nucleic Acids Research | Not publicly disclosed | 13.1 | CiteScore 31.7, h5-index 233 | Mechanistic nucleic-acid biology and durable tools |
Genome Biology | Not publicly disclosed | 10.4 | Strong genomics and systems-biology signal | Flagship genomics narratives |
Genome Research | Not publicly disclosed | 5.6 | Strong genomic identity, lower citation ceiling | Focused genome-centric stories |
Bioinformatics | Not publicly disclosed | 5.8 | More method-specific readership | Computational methods first |
Nature Methods | Much more selective | 36.1 | Prestige-tier methods signal | Field-shaping methods and platforms |
This is the important positioning: NAR is not a generic "good molecular-biology journal." It is a specialized high-trust venue whose value comes from combining fast handling, strong citation performance, and a culture that rewards either mechanistic clarity or community utility.
What the acceptance-rate question really means here
For NAR, the acceptance-rate query is really a proxy for two harder questions:
- Will this paper survive editorial triage?
- Is the contribution the kind of thing NAR readers keep citing for years?
That is why guessed percentages are not very useful here.
What the query does tell you:
- NAR is selective enough that broad descriptive studies get cut quickly
- editorial speed means weak positioning is exposed early
- article type matters a lot because resources, methods, and research articles behave differently
What it does not tell you:
- how the Database Issue and Web Server Issue differ from standard research submissions
- how much faster resource papers are screened than broad research papers
- whether the manuscript is failing on scope, mechanism, or utility
What NAR editors are actually screening for
The official scope and the handling pattern point to a narrow editorial logic:
- Does the paper deliver deep molecular mechanism or a clearly durable resource?
- Is the contribution specific to nucleic-acid biology rather than generally molecular?
- For methods or resources, is the community value obvious rather than hypothetical?
- For research articles, is the manuscript more than descriptive?
NAR is one of the journals where "useful but broad" is often not enough. The bar is sharper than that.
Readiness check
See how your manuscript scores against Nucleic Acids Research before you submit.
Run the scan with Nucleic Acids Research as your target journal. Get a fit signal alongside the IF context.
What we see in pre-submission review work
In our pre-submission review work, three patterns appear again and again with NAR-targeting manuscripts.
The paper is descriptive when it needs to be mechanistic. A genomics or RNA paper may be clean, data-rich, and interesting, but if the manuscript stops at association, cataloging, or broad profiling without a sharper mechanistic claim, the fit becomes fragile.
The tool or resource is real but not clearly indispensable. NAR has a long history of papers that become field infrastructure. That raises the bar. A database or software resource that is only incrementally different from existing tools is hard to justify here.
The manuscript is broad when the journal wants focus. We repeatedly see papers with ambitious scope but diluted claims. NAR tends to reward sharper, more defensible framing rather than wider but looser storytelling.
This is where fast triage matters. SciRev community handling data still points to very short immediate-rejection times, which matches what authors experience in practice.
The better submission question
For NAR, the better decision question is:
Is this manuscript either mechanistically sharp enough or useful enough that the journal's editorial team can justify sending it to review quickly?
If yes, the missing public acceptance rate is not a blocker. If no, the rate would not help anyway.
Submit if / Think twice if
Submit if:
- the paper has real mechanistic depth in nucleic-acid biology
- the tool, database, or method has obvious long-term field value
- the framing is tight enough to survive fast editorial triage
- the journal's readership is clearly the audience you need
Think twice if:
- the manuscript is mostly descriptive profiling
- the method is solid but belongs more naturally in Bioinformatics or Genome Biology
- the resource is incremental rather than field-shaping
- the paper needs a broader genomics narrative venue rather than a nucleic-acid-focused one
Practical verdict
The honest answer is that NAR does not publish a clean live public acceptance rate.
The useful answer is:
- the journal is clearly selective
- the current editorial timing confirms very fast triage
- authors should optimize for mechanism, utility, and tight framing rather than for any guessed percentage
If you want a reviewer-style read on whether the manuscript behaves like a real NAR paper before upload, a NAR submission readiness check is the best next step.
Frequently asked questions
No. Oxford Academic publishes current editorial timing and citation metrics for Nucleic Acids Research, but it does not publish a live public acceptance-rate figure on the main journal information pages.
Whether the manuscript offers real mechanistic depth or durable community utility. NAR is unusually fast at triage, and broad descriptive work often fails before any unofficial acceptance-rate estimate becomes useful.
NAR currently reports a 2024 impact factor of 13.1, a 2024 CiteScore of 31.7, and median 2025 times of 18 days to first decision and 23 days to final decision. Those figures confirm it is both high impact and editorially fast.
NAR is broader across nucleic-acid biology, high-utility resources, and methods. Genome Biology is a stronger fit for flagship genomics narratives, while Bioinformatics is narrower when the real contribution is computational method development.
A paper that is technically competent but too descriptive, too broad, or too thin on mechanism. NAR's editorial screen consistently favors work with sharp mechanistic insight or obvious long-term community value.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: whether the package is ready, what drives desk rejection, how journals compare, and what the submission requirements look like across journals.
Checklist system / operational asset
Elite Submission Checklist
A flagship pre-submission checklist that turns journal-fit, desk-reject, and package-quality lessons into one operational final-pass audit.
Flagship report / decision support
Desk Rejection Report
A canonical desk-rejection report that organizes the most common editorial failure modes, what they look like, and how to prevent them.
Dataset / reference hub
Journal Intelligence Dataset
A canonical journal dataset that combines selectivity posture, review timing, submission requirements, and Manusights fit signals in one citeable reference asset.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Before you upload
Want the full picture on Nucleic Acids Research?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Is Nucleic Acids Research a Good Journal? Fit Verdict
- Nucleic Acids Research submission guide
- Nucleic Acids Research Review Time 2026: How Long to First Decision?
- How to Avoid Desk Rejection at Nucleic Acids Research (2026)
- Nucleic Acids Research Impact Factor 2026: 13.1, Q1, Rank 13/319
- Is Your Paper Ready for Nucleic Acids Research? A Guide to NAR's Three Editorial Tracks
Compare alternatives
Supporting reads
Want the full picture on Nucleic Acids Research?
These pages attract evaluation intent more than upload-ready intent.